Hypocretin neuropeptide precursor
experimentalAlso known as: Hypocretin, Orexin precursor, Prepro-orexin, Preprohypocretin, HCRT, O43612
The hypocretin neuropeptide precursor (prepro-orexin) is a 131-amino acid polypeptide encoded by the *HCRT* gene, which is proteolytically processed into two mature neuropeptides: hypocretin-1 (orexin-A) and hypocretin-2 (orexin-B). These peptides act primarily via two G-protein-coupled receptors, OX1R and OX2R, which are expressed in the hypothalamus and other brain regions. Hypocretins are critical for stabilizing wakefulness and promoting arousal, while also modulating feeding behavior, energy homeostasis, and reward processing. The mechanism involves excitatory signaling that coordinates the transition between sleep and wake states, with hypocretin neurons projecting to monoaminergic and cholinergic arousal centers. Key research findings indicate that loss of hypocretin-producing neurons in the lateral hypothalamus is a primary cause of narcolepsy type 1 in humans and animal models. Experimental studies have demonstrated that hypocretin administration promotes wakefulness and suppresses rapid eye movement (REM) sleep, while hypocretin receptor antagonists (e.g., suvorexant) are used clinically for insomnia. Additionally, hypocretin signaling influences appetite and energy expenditure, with dysregulation linked to obesity and metabolic disorders. Current research explores hypocretin-based therapies for narcolepsy, sleep disorders, and potentially for conditions involving arousal dysregulation. Clinically, hypocretin deficiency is a diagnostic biomarker for narcolepsy type 1, and hypocretin receptor agonists are under investigation for treating hypersomnia. However, the precursor itself remains experimental, with limited translational applications due to its short half-life and challenges in central nervous system delivery. Further studies are needed to clarify its role in comorbid conditions such as depression, addiction, and neurodegenerative diseases. For research purposes only — not medical advice.
Key data
MNLPSTKVSWAAVTLLLLLLLLPPALLSSGAAAQPLPDCCRQKTCSCRLYELLHGAGNHAAGILTLGKRRSGPPGLQGRLQRLLQASGNHAAGILTMGRRAGAEPAPRPCLGRRCSAPAAASVAPGGQSGIMechanism of action
Neuropeptides that play a significant role in the regulation of food intake and sleep-wakefulness, possibly by coordinating the complex behavioral and physiologic responses of these complementary homeostatic functions. A broader role in the homeostatic regulation of energy metabolism, autonomic function, hormonal balance and the regulation of body fluids, is also suggested
Research & studies
ADPKD patients had significantly higher serum orexin-A levels (477.07 pg/mL) compared to controls (321.49 pg/mL).; Orexin-A inversely correlated with systolic blood pressure in ADPKD patients.; Orexin-A directly correlated with eGFR in ADPKD patients.; No association was found between analyzed SNPs and orexin-A levels in ADPKD.
rs29230 genotype and allele frequencies differed significantly between cases and controls (p=0.0205 and p=0.0191; OR=0.493).; rs29230 showed significant differences in male patients and overweight subgroup (p=0.0259 and p=0.0333, respectively).; rs1801278 allele and genotype frequencies were significantly different between cases and controls (p=0.0488 and p=0.0471).; No significant association was found between rs9902709 and OSAHS risk (p=0.2762).
Frequently asked questions
What is Hypocretin neuropeptide precursor?
The hypocretin neuropeptide precursor (prepro-orexin) is a 131-amino acid polypeptide encoded by the *HCRT* gene, which is proteolytically processed into two mature neuropeptides: hypocretin-1 (orexin-A) and hypocretin-2 (orexin-B). These peptides act primarily via two G-protein-coupled receptors, OX1R and OX2R, which
How does Hypocretin neuropeptide precursor work?
Neuropeptides that play a significant role in the regulation of food intake and sleep-wakefulness, possibly by coordinating the complex behavioral and physiologic responses of these complementary homeostatic functions. A broader role in the homeostatic regulation of energy metabolism, autonomic function, hormonal balance and the regulation of body fluids, is also suggested
What is the research status of Hypocretin neuropeptide precursor?
Hypocretin neuropeptide precursor is currently classified as experimental, with 9 research references on record. This is for research purposes only and is not medical advice.
What is the molecular weight of Hypocretin neuropeptide precursor?
Hypocretin neuropeptide precursor has a molecular weight of approximately 13363 g/mol.
Related peptides
CNTF-derived peptidergic compound that promotes neurogenesis and reduces tau pathology in preclinical Alzheimer's models.
33-aa hypothalamic neuropeptide acting on OX1/OX2 receptors to promote wakefulness and arousal.
Porcine brain-derived peptide preparation with neurotrophic-factor-like activity studied in stroke, TBI, and dementia.
Ligand for NPSR1 . Binds to its receptor with nanomolar affinity and initiates a G /GNAQ-dependent phospholipase C-activating signaling pathway. This results in Ca mobilization from intracellular stores and increased int…
NCAM-derived FG-loop peptide that activates FGFR1 to enhance synaptic plasticity and memory in animal models.
May function as an output molecule from the suprachiasmatic nucleus that transmits behavioral circadian rhythm.
Build on Hypocretin neuropeptide precursor data programmatically
Structured peptide data, semantic search, and AI summaries via one API.
Get a free API key